N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI

Experimental Neurology

Volumn 257, Issue , 2014, Pages 106-113

  Pandya, Jignesh D ^a   Readnower, Ryan D ^a   Patel, Samir P ^a   Yonutas, Heather M ^a   Pauly, James R ^a,b   Goldstein, Glenn A ^c   Rabchevsky, Alexander G ^a   Sullivan, Patrick G ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE DERIVATIVE; GLUTATHIONE; N ACETYLCYSTEINE AMIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CELL ENERGY; CELL MEMBRANE PERMEABILITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG MECHANISM; MALE; MENTAL FUNCTION; MITOCHONDRIAL MEMBRANE; MORRIS WATER MAZE TEST; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY;

ACETYLCYSTEINE; ALDEHYDES; ANIMALS; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DOUBLE-BLIND METHOD; ENERGY METABOLISM; GLUTATHIONE; MALE; MAZE LEARNING; MITOCHONDRIA; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; OXYGEN CONSUMPTION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TYROSINE;

EID: 84900851451     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.04.020     Document Type: Article

References (59)

1. Abdel Baki S.G., Schwab B., Haber M., Fenton A.A., Bergold P.J. Minocycline synergizes with N-acetylcysteine and improves cognition and memory following traumatic brain injury in rats. PLoS ONE 2010, 5:e12490.
2. Ansari M.A., Roberts K.N., Scheff S.W. Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radic. Biol. Med. 2008, 45:443-452.
3. Ansari M.A., Roberts K.N., Scheff S.W. A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI. J. Neurotrauma 2008, 25:513-526.
4. Arundine M., Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell. Mol. Life Sci. 2004, 61:657-668.
5. Atlas D., Melamed E., Offen D. Brain targeted low molecular weight hydrophobic antioxidant compounds 1999.
6. Avery M.A., Rooney T.M., Pandya J.D., Wishart T.M., Gillingwater T.H., Geddes J.W., Sullivan P.G., Freeman M.R. WldS prevents axon degeneration through increased mitochondrial flux and enhanced mitochondrial Ca2+ buffering. Curr. Biol. 2012, 22:596-600.
7. Bartov O., Sultana R., Butterfield D.A., Atlas D. Low molecular weight thiol amides attenuate MAPK activity and protect primary neurons from Abeta(1-42) toxicity. Brain Res. 2006, 1069:198-206.
8. Budd S.L., Nicholls D.G. A reevaluation of the role of mitochondria in neuronal Ca2+ homeostasis. J. Neurochem. 1996, 66:403-411.
9. Chen G., Shi J., Hu Z., Hang C. Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine. Mediat. Inflamm. 2008, 2008:716458.
10. Choi D.W., Maulucci-Gedde M., Kriegstein A.R. Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 1987, 7:357-368.
11. Davis L.M., Pauly J.R., Readnower R.D., Rho J.M., Sullivan P.G. Fasting is neuroprotective following traumatic brain injury. J. Neurosci. Res. 2008, 86:1812-1822.
12. Doppenberg E.M., Bullock R. Clinical neuro-protection trials in severe traumatic brain injury: lessons from previous studies. J. Neurotrauma 1997, 14:71-80.
13. Dykens J.A. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration. J. Neurochem. 1994, 63:584-591.
14. Ellis E.F., Dodson L.Y., Police R.J. Restoration of cerebrovascular responsiveness to hyperventilation by the oxygen radical scavenger n-acetylcysteine following experimental traumatic brain injury. J. Neurosurg. 1991, 75:774-779.
15. Faden A.I., Demediuk P., Panter S.S., Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989, 244:798-800.
16. Fiskum G. Mitochondrial participation in ischemic and traumatic neural cell death. J. Neurotrauma 2000, 17:843-855.
17. Gilgun-Sherki Y., Rosenbaum Z., Melamed E., Offen D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev. 2002, 54:271-284.
18. Grinberg L., Fibach E., Amer J., Atlas D. N-acetylcysteine amide, a novel cell-permeating thiol, restores cellular glutathione and protects human red blood cells from oxidative stress. Free Radic. Biol. Med. 2005, 38:136-145.
19. Haber M., Abdel Baki S.G., Grin'kina N.M., Irizarry R., Ershova A., Orsi S., Grill R.J., Dash P., Bergold P.J. Minocycline plus N-acetylcysteine synergize to modulate inflammation and prevent cognitive and memory deficits in a rat model of mild traumatic brain injury. Exp. Neurol. 2013, 249C:169-177.
20. Hall E.D., Bryant Y.D., Cho W., Sullivan P.G. Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods. J. Neurotrauma 2008, 25:235-247.
21. Halliwell B. Drug antioxidant effects. A basis for drug selection?. Drugs 1991, 42:569-605.
22. Hicdonmez T., Kanter M., Tiryaki M., Parsak T., Cobanoglu S. Neuroprotective effects of N-acetylcysteine on experimental closed head trauma in rats. Neurochem. Res. 2006, 31:473-481.
23. Hoffer M.E., Balaban C., Slade M.D., Tsao J.W., Hoffer B. Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study. PLoS ONE 2013, 8:e54163.
24. Ichas F., Mazat J.P. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim. Biophys. Acta 1998, 1366:33-50.
25. Maxwell W.L., Povlishock J.T., Graham D.L. A mechanistic analysis of nondisruptive axonal injury: a review. J. Neurotrauma 1997, 14:419-440.
26. Offen D., Gilgun-Sherki Y., Barhum Y., Benhar M., Grinberg L., Reich R., Melamed E., Atlas D. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis. J. Neurochem. 2004, 89:1241-1251.
27. Opii W.O., Nukala V.N., Sultana R., Pandya J.D., Day K.M., Merchant M.L., Klein J.B., Sullivan P.G., Butterfield D.A. Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury. J. Neurotrauma 2007, 24:772-789.
28. Pandya J.D., Pauly J.R., Nukala V.N., Sebastian A.H., Day K.M., Korde A.S., Maragos W.F., Hall E.D., Sullivan P.G. Post-injury administration of mitochondrial uncouplers increases tissue sparing and improves behavioral outcome following traumatic brain injury in rodents. J. Neurotrauma 2007, 24:798-811.
29. Pandya J.D., Pauly J.R., Sullivan P.G. The optimal dosage and window of opportunity to maintain mitochondrial homeostasis following traumatic brain injury using the uncoupler FCCP. Exp. Neurol. 2009, 218:381-389.
30. Pandya J.D., Nukala V.N., Sullivan P.G. Concentration dependent effect of calcium on brain mitochondrial bioenergetics and oxidative stress parameters. Front. Neuroenerg. 2013, 5:10.
31. Patel S.P., Sullivan P.G., Pandya J.D., Goldstein G.A., VanRooyen J.L., Yonutas H.M., Eldahan K.C., Morehouse J., Magnuson D.S.K., Rabchevsky A.G. N-acetylcysteineamide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma. Exp. Neurol. 2014, 10.1016/j.expneurol.2014.04.026.
32. Penugonda S., Mare S., Goldstein G., Banks W.A., Ercal N. Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12. Brain Res. 2005, 1056:132-138.
33. Readnower R.D., Pandya J.D., McEwen M.L., Pauly J.R., Springer J.E., Sullivan P.G. Post-injury administration of the mitochondrial permeability transition pore inhibitor, NIM811, is neuroprotective and improves cognition after traumatic brain injury in rats. J. Neurotrauma 2011, 28:1845-1853.
34. Reed T.T., Owen J., Pierce W.M., Sebastian A., Sullivan P.G., Butterfield D.A. Proteomic identification of nitrated brain proteins in traumatic brain-injured rats treated postinjury with gamma-glutamylcysteine ethyl ester: insights into the role of elevation of glutathione as a potential therapeutic strategy for traumatic brain injury. J. Neurosci. Res. 2009, 87:408-417.
35. Rizzuto R., Bernardi P., Pozzan T. Mitochondria as all-round players of the calcium game. J. Physiol. 2000, 529(Pt 1):37-47.
36. Royo N.C., Shimizu S., Schouten J.W., Stover J.F., McIntosh T.K. Pharmacology of traumatic brain injury. Curr. Opin. Pharmacol. 2003, 3:27-32.
37. Sauerbeck A., Gao J., Readnower R., Liu M., Pauly J.R., Bing G., Sullivan P.G. Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury. Exp. Neurol. 2011, 227:128-135.
38. Sauerbeck A., Pandya J., Singh I., Bittman K., Readnower R., Bing G., Sullivan P. Analysis of regional brain mitochondrial bioenergetics and susceptibility to mitochondrial inhibition utilizing a microplate based system. J. Neurosci. Methods 2011, 198:36-43.
39. Scheff S.W., Sullivan P.G. Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J. Neurotrauma 1999, 16:783-792.
40. Scheff S.W., Baldwin S.A., Brown R.W., Kraemer P.J. Morris water maze deficits in rats following traumatic brain injury: lateral controlled cortical impact. J. Neurotrauma 1997, 14:615-627.
41. Sims N.R., Nilsson M., Muyderman H. Mitochondrial glutathione: a modulator of brain cell death. J. Bioenerg. Biomembr. 2004, 36:329-333.
42. Singh I.N., Sullivan P.G., Deng Y., Mbye L.H., Hall E.D. Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy. J. Cereb. Blood Flow Metab. 2006, 26:1407-1418.
43. Starkov A.A., Fiskum G. Regulation of brain mitochondrial H2O2 production by membrane potential and NAD(P)H redox state. J. Neurochem. 2003, 86:1101-1107.
44. Stelmasiak Z., Dudkowska-Konopa A., Rejdak K. Head trauma and neuroprotection. Med. Sci. Monit. 2000, 6:426-432.
45. Sullivan P.G., Thompson M.B., Scheff S.W. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp. Neurol. 1999, 160:226-234.
46. Sullivan P.G., Geiger J.D., Mattson M.P., Scheff S.W. Dietary supplement creatine protects against traumatic brain injury. Ann. Neurol. 2000, 48:723-729.
47. Sullivan P.G., Thompson M., Scheff S.W. Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury. Exp. Neurol. 2000, 161:631-637.
48. Sullivan P.G., Rippy N.A., Dorenbos K., Concepcion R.C., Agarwal A.K., Rho J.M. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 2004, 55:576-580.
49. Sullivan P.G., Springer J.E., Hall E.D., Scheff S.W. Mitochondrial uncoupling as a therapeutic target following neuronal injury. J. Bioenerg. Biomembr. 2004, 36:353-356.
50. Sullivan P.G., Rabchevsky A.G., Waldmeier P.C., Springer J.E. Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death?. J. Neurosci. Res. 2005, 79:231-239.
51. Sullivan P.G., Krishnamurthy S., Patel S.P., Pandya J.D., Rabchevsky A.G. Temporal characterization of mitochondrial bioenergetics after spinal cord injury. J. Neurotrauma 2007, 24:991-999.
52. Sunitha K., Hemshekhar M., Thushara R.M., Santhosh M.S., Yariswamy M., Kemparaju K., Girish K.S. N-Acetylcysteine amide: a derivative to fulfill the promises of N-acetylcysteine. Free Radic. Res. 2013, 47:357-367.
53. Thomale U.W., Griebenow M., Kroppenstedt S.N., Unterberg A.W., Stover J.F. The antioxidant effect of N-acethylcysteine on experimental contusion in rats. Acta Neurochir. Suppl. 2005, 95:429-431.
54. Thomale U.W., Griebenow M., Kroppenstedt S.N., Unterberg A.W., Stover J.F. The effect of N-acetylcysteine on posttraumatic changes after controlled cortical impact in rats. Intensive Care Med. 2006, 32:149-155.
55. Thurman D.J., Alverson C., Dunn K.A., Guerrero J., Sniezek J.E. Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 1999, 14:602-615.
56. Xiong Y., Peterson P.L., Lee C.P. Effect of N-acetylcysteine on mitochondrial function following traumatic brain injury in rats. J. Neurotrauma 1999, 16:1067-1082.
57. Yi J.H., Hazell A.S. N-acetylcysteine attenuates early induction of heme oxygenase-1 following traumatic brain injury. Brain Res. 2005, 1033:13-19.
58. Yi J.H., Hoover R., McIntosh T.K., Hazell A.S. Early, transient increase in complexin I and complexin II in the cerebral cortex following traumatic brain injury is attenuated by N-acetylcysteine. J. Neurotrauma 2006, 23:86-96.
59. Zipfel G.J., Babcock D.J., Lee J.M., Choi D.W. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J. Neurotrauma 2000, 17:857-869.